I'm with you ajostu.
Unless NEU receives an offer they can't refuse, they are in a holding pattern until the Rett phase 2a trial results are published. If they are positive, there is the implication that larger doses given to those suffering from Fragile X syndrome would produce similar results.
That would put NEU in a far stronger negotiating position that they are currently.
Ann: Neuren receives $0.9m from exercise of last expiring options-NEU.AX, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.95 |
Change
-0.010(0.08%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $2.460M | 190.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 566 | $12.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.96 | 844 | 11 |
View Market Depth
| Last trade - 13.33pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |